Journal
CURRENT OPINION IN CHEMICAL ENGINEERING
Volume 7, Issue -, Pages 84-92Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coche.2014.12.003
Keywords
-
Funding
- National Institutes of Health [1R01-EB00246-20]
- David Spencer is a recipient of National Science Foundation Graduate Research Fellowship
Ask authors/readers for more resources
Treatment of cancer using nanoparticle-based approaches relies on the rational design of carriers with respect to size, charge, and surface properties. Polymer-based nanomaterials, inorganic materials such as gold, iron oxide, and silica as well as carbon based materials such as carbon nanotubes and graphene are being explored extensively for cancer therapy. The challenges associated with the delivery of these nanoparticles depend greatly on the type of cancer and stage of development. This review highlights design considerations to develop nanoparticle-based approaches for overcoming physiological hurdles in cancer treatment, as well as emerging research in engineering advanced delivery systems for the treatment of primary, metastatic, and multidrug resistant cancers. A growing understanding of cancer biology will continue to foster development of intelligent nanoparticle-based therapeutics that take into account diverse physiological contexts of changing disease states to improve treatment outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available